Skip to main content

Rafferty Asset Management, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1389426 New York, NY

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
180,471
+5.3% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 180,471
2025-12-31 171,456
2025-09-30 168,352
2025-06-30 143,852
2025-03-31 180,134
2024-12-31 241,474
2024-09-30 204,146
2024-06-30 241,982
2024-03-31 148,801
2023-12-31 143,118
2023-09-30 214,161
2023-06-30 92,268
2023-03-31 109,398
2022-12-31 164,104
2022-09-30 102,572
2022-06-30 92,889
2022-03-31 123,495
2021-12-31 125,910
2021-09-30 89,199
2021-06-30 41,991
2021-03-31 71,412
2020-12-31 18,759
2020-09-30 69,229
2020-06-30 30,819
2020-03-31 8,262